Boundless Bio, Inc.

BOLD - CIK 0001782303

Market cap-

Rank-

SEC filings127

BOLD balance sheet (annual)

The table below shows Boundless Bio, Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024
Cash & equivalents	$17.87M	$26.59M
Short-term investments	$89.71M	$125.53M
Receivables	-	-
Inventory	-	-
Total current assets	$109.61M	$154.39M
Property, plant & equipment	$3.22M	$4.32M
Goodwill	-	-
Total assets	$157.06M	$206.41M
Accounts payable	$1.49M	$1.27M

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.